CCCC
C4 Therapeutics Inc
3.00$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -19.3% | +238.4% | +26.6% | -15.0% | -12.6% | -7.1% | +2.7% | |
| – | -21.7% | +293.7% | -14.5% | -11.7% | -5.7% | -4.9% | +0.1% | |
| – | +149.4% | +100.7% | -58.1% | -60.9% | +325.5% | -56.2% | +34.4% | |
| – | +149.4% | +310.5% | -16.8% | -10.7% | -8.1% | -3.5% | +1.5% | |
| – | -94.7% | -3.0% | +27.5% | -74.2% | +701.0% | -73.7% | -22.6% | |
| – | +0.0% | – | – | – | – | – | – | |
| – | -7.2% | -12.5% | -81.2% | +138.1% | – | – | – | |
| – | +1.8% | -48.2% | -1.8% | +20.9% | -8.0% | +2.5% | -23.3% | |
| – | +40.5% | +30.4% | +16.9% | -13.1% | -4.0% | +5.6% | -26.9% | |
| – | +19.9% | +18.4% | +28.0% | +423.8% | -25.3% | +10.6% | +10.3% | |
| – | +366.6% | +5.5% | -20.7% | -74.0% | +23.4% | -8.2% | -35.4% | |
| – | – | – | +7.1% | -14.6% | – | – | – | |
| – | – | – | +38.8% | -25.8% | -14.9% | -12.2% | +18.8% | |
| – | – | – | – | – | – | – | – | |
| – | +2.1% | +0.2% | +6.9% | +6.1% | +1.6% | +39.8% | +19.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.